Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap10.57B
Enterprise Value9.61B
P/E Ratio360.24
PEG Ratio-0.11
Price/Sales Ratio1.92
Price/Book Ratio1.15
Enterprise/Revenue1.66
Enterprise/EBITDA23.11

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue4.9B
Revenue/Share1.42
Gross Profit2.65B
EBITDA466M
Net Income18.5M
Diluted EPS0.01

Balance Sheet

Total Cash1.56B
Total Cash/Share0.47
Total Debt351.59M
Total Debt/Equity0.04
Current Ratio4.7
Book Value Per Share2.65

Price History

52-Week Change-19.19
52-Week High4.49
52-Week Low2.89
Moving Average 50 Days3.32
Moving Average 200 Days3.58

Statistics

Average Volume34.19M
Shares Outstanding3B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield1
Payout Ratio7.75
Last Split Factor3:1
Last Split DateOctober 26, 2016
AD